They come to me and they show me their phone and say, I want this, Chammout says
In a two-month period from December to February, 143 new lawsuits joined the consolidated litigation against Ely Lilly and other GLP-1 drug manufacturers, bringing the pending lawsuit total to 1,443
Insomnia treatment studies looking at DSIP for insomnia have produced contradictory results
Managing a medication like tirzepatide often requires ongoing communication with healthcare providers
Additionally, these nutrients help to maintain low levels of homocysteine, a potentially toxic chemical that can lead to stroke and atherosclerosis
In Ontario, if the drug is considered under the Exceptional Access Program (EAP), include a copy of the EAP approval or denial with this form